Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just got mine in the mail :) “Medolife Rx expects to begin producing and selling new batches of the Immunapen product line starting in Q1 2023”
https://medoliferx.com/
I personal use the “Escozine Immunapen Original Drops” but I have tried the others and like them as well
As per the December 2022 PR, MedolifeRx HAS delivered its new immunipen formula! I have the immunipen delivered on an auto ship basis - and just received the newly reformulated immunipen!!
I really like this updated formula - the viscosity & flavor Is great!!
I’ve been using the imunapen for a long time now and really do feel they work as advertised. Let’s hope this roll out of the revised immunipens is a positive sign for 2023
Here’s a quote that I’m referring to from that PR ; [{ “reformulating the pens at this time with the goal of increasing the potency of the product line. Medolife Rx expects to begin producing and selling new batches of the Immunapen product line starting in Q1 2023.”}]
https://finance.yahoo.com/news/quanta-medolife-rx-updates-activities-171200121.html
Arthur being silent this long should clearly show the investment community he is a common thief and scum. Hopefully he is prosecuted to the fullest extent of the law. He needs to be sent to prison in the Dominican Republic.
Responsible CEO's Conduct business and are physically available;_criminals_hide!
Where exactly is Moochaelian if you think he.is.working? Or do you consider disappearing with everyone's money and being on the run meritorious, advantageous, and worthy of praise?
Time will tell … however, it’s my personal opinion that they are not doing the same thing over and over … in the face of a lot of challenging things they haven’t given up … things might appear outwardly to be going slowly - however they were incredibly forth coming in the last 2022 Dec PR … they mentioned the imunapen getting reformulated and should appear (hopefully) Q1 of this year (ie hopefully soon) …
QNTA wasn’t the “immediate” slam dunk we thought would be a couple springs ago … HOWEVER.. they haven’t given up … the 20 years of research is impressive.. when you Google how many attempts in the pharma world fail and more never leave the drawing boards it’s a massive percentage… stock SP is abysmal looking - sadly true … but it’s not “zero” …
Here’s to 2023 being it’s year and we all see green
((Obviously EVERYONE has to do what’s best for themselves… I myself like and use their products… as a share holder I want them to succeed as then obviously then we all succeed too))
As far as the "company" addressing these matters:
Everyone sees the results of the Moochaelian handywork.
“Insanity is doing the same thing over and over again and expecting different results.” ~ Albert Einstein
“Two things are infinite: the universe and human stupidity; and I am not sure about the universe.” ~ Albert Einstein
“We cannot solve our problems with the same thinking we used when we created them.” ~ Albert Einstein
Key words ; “has not commenced”
[{“As previously announced, the Company is the subject of an ongoing SEC investigation and has received a Wells Notice. At this time, the SEC has not commenced an enforcement action against us, but the investigation remains open and ongoing. Accordingly, we cannot further comment on this matter at this time.”}]
https://finance.yahoo.com/news/quanta-medolife-rx-updates-activities-171200121.html
“In the recent months, the Company has been focused on navigating through serious challenges. The Company acknowledges the drop in the price of its common stock and the delinquent status with the SEC reporting requirements. The Company provides this update on both its corporate and operational status and its plans to address these matters.”
Who knows! I can guarantee you he will pay one way or another. He can only hide so long.
He is not going to pay nothing, on the other hand, he got paid for his swindle efforts that all us funded very silly. Like a kid getting his lollypop away by a big bully. We got suckered and served, LEGALLY. This is why there is a BIG sign at the OTCM door, "At Your Own Risk" and this where fool money is found. Smart money never comes here, this is for gamblers and stupid ones. GL AND VIVA QNTA!!!
QNTA is done! Arthur’s scam has finally caught up with him. He will pay the price in the long run. The guy is total scum.
Quoting their last PR; “In the recent months, the Company has been focused on navigating through serious challenges.” …
You asked is Santa coming???
Let’s hope so …
It’s a new year … let’s hope the fact that they haven’t given up proves ultimately (eventually) to benefit us all … the sp Is freakishly dismal … but hopefully their continued gumption to achieve goals based on almost 20 years of research culminates this year …
I’ve ReRead the pr (I pulled the above quote from it) .. when reading it there is a lot to unpack … In the mean time they definitely have perseverance, that’s good … let’s hope 2023 things come together as outlined …
https://www.stocktitan.net/news/QNTA/quanta-and-medolife-rx-provide-updates-on-activities-and-wods6rv17bhq.html
Very true! Arthur is a dumb ass! He is a incompetent fool.
Wait , Santa's not coming ???
Too much time has gone by for any investor payback. I can guarantee you he will pay the price for his scam!
The only lessons taught were to those of us who invested in this now worthless stock.
Expecting this thing to make some miraculous turn around is as foolish as a grown man sitting by the fireplace in his pj's waiting for Santa to drop down the chimney with a Lambo.
Arthur is just a Scumbag! He will be taught a lesson he will never forget. Too much time frame has gone on for any salvation.
I mean no disrespect ma'am, but it's irrelevant to shareholders that are staring at ridiculous losses that the odds of recouping on are very slim to none
Hopefully…. It’s not irrelevant
Thoroughly irrelevant at this point, shame...
scam
/skam/
nouninformal
noun: scam; plural noun: scams
a dishonest scheme; a fraud.
"an insurance scam"
fraud
swindle
fraudulent scheme
racket
trick
diddle
con
con trick
flimflam
kite
ramp
twist
hustle
grift
shakedown
bunco
boondoggle
rort
verb
verb: scam; 3rd person present: scams; past tense: scammed; past participle: scammed; gerund or present participle: scamming
swindle.
"a guy that scams the elderly out of their savings"
synonyms for scam
blackmail
deceit
deception
extortion
fraud
hoax
racket
ripoff
shakedown
sham
cheating
con
double-dealing
flimflam
hosing
hustle
sting
con game
“SEC alleges”; & What is the meaning of alleges? verb. : to assert without proof
Einstein analyzes and describes supporters of Moochaelian's scam:
“Insanity is doing the same thing over and over again and expecting different results.” ~ Albert Einstein
“Two things are infinite: the universe and human stupidity; and I am not sure about the universe.” ~ Albert Einstein
“We cannot solve our problems with the same thinking we used when we created them.” ~ Albert Einstein
The following agency in the DR gave award to Dr Mikaelian
http://www.defensacivil.gob.do/
Medolife Rx CEO Receives Achievement Award From Regulatory Agency in the Dominican Republic for Work on COVID-19 Treatment”
Link to article
https://d1io3yog0oux5.cloudfront.net/_0294c22df87ec38579fb79262886a806/quantrx/news/2021-05-18_Medolife_Rx_CEO_Receives_Achievement_Award_From_68.pdf
I believe the stuff is real because I use the muscle rub and immunapen I find the products effective
As per the last PR … here’s where AELIA can be found on Amazon https://www.amazon.com/AELIA-All-Natural-Polarized-Targeted-Soreness/dp/B09H3QX8GD
As for the Dr degrees and credentials Yes I do believe in his resume
They have most certainly down sized as per the pr the cash is an issue at the moment… but for me, I am in a position where my option is to keep holding
https://www.facebook.com/1938573129712872/posts/pfbid0KnMMakRv2z4MKVug2goWaYyLy29WfQLpXVwMRonHcKDYNEPLgg5YqetGnHYA4wfUl/?mibextid=cr9u03
Do you have proof he holds all those credentials from such university? A professional with etiquette, would never allowed to be involved in such embarrassment. I am an engineer and we have a bound to and for humanity, not different than an attorney or a doctor. This guy is a dancer and scammer. Do you still believe the SCORPION VENOM TECH was real? Shucks!!!! Ask Dragon Lady!!! She was #1 defender of QNTA until she made a trip DR!!! What did she find? If any, to have changed of heart like this!!! I sent my cousin to DR and found a small empty office to the address of such in DR. Also he went to the Scorpion Venom center , in a place called Nagua, I believe, they were looking at my cousin like a clown. Not idea what he was talking about. Nobody knows crap of such. He couldn’t find in local pharmacies the Aelia products either…. I can’t make this up!!! Last thing Qnta needs is current team sniffing around.
He may have a lot of knowledge and needs to be part of QNTA, but he is still an idiot for not realizing his lack of ability to run this organization. It’s time to hire a leader to get control of this mess.
DEFINITELY needs to remain an integral part of QNTA
Decades of culmination of Dr Mikaelians research - it his his science we’ve invested in .. Dr. Mikaelian is an international scholar / scientist who is fluent in multiple languages …
If you look back at the last few PRs QNTA put forth their plan ti bring on some one who has the very background of propelling MedilifeRx type companies forward / has successfully navigated the seemingly endless fda process …. The only thing is, unfortunately last year was like Murphy’s law was all over qnta …. I still like, use and believe in the products And I admire the perseverance of Dr Mikaelian for continuing his decades of research and seeking to accomplish his goals for the company … for me, I’m holding shares and supporting Dr Mikaelian, I believe in them.
“For the past 20 years Dr. Mikaelian has been independently actively studying stress hormones (cortisol, epinephrine), master gene (ATF3) and their indirect influences on cancer cell activity and tumor progression.”
“Dr. Mikaelian’s technical education began at the 2nd Medical Institute of Moscow and continued at the Vernadsky University of Biosphere Knowledge in Moscow, where he earned his doctorate in Biological Psychology; he then went on to complete his post-doctorate work at Vernadsky. He also earned an MBA from the University of Bologna in Italy.”
Arthur still needs to be part of the QNTA team. He can and will provide some value. Plain and simple, this company needs a new leader.
Absurd bullshit. How is someone who is not productive indispensable? Other than those profiting from the fraud and gravy train, who would want him to remain?
Disagree! The only way to figure out if QNTA has any value or potential is to bring somebody in from outside. Investors could very easily cover their expense for a period of time. There are several investors who have lost a lot of investment money due to Arthur’s inabilities to run a business. I personally know of several people and investment funds who have lost in excess of 200 K each.
Too late to be calling A.M to step down. It won’t make any difference now. Just bent on your knees, he likes to use lube, let him do you and don’t say anything. Just hold the pain to yourself and let go. He won’t last long, don’t worry, you won’t die from this
I agree with that assessment. eom
We remove this POS as you call it, shareholders can say good bye for sure to their money. Let’s wait for a miracle, hopefully he makes a comeback and we can get our money back
Wake Up! Arthur needs to step down! He is so far over his head, it’s a joke.
While your thinking is good intentioned, I can assure you the lawyers will explore the 'deep pockets' of QNTA and will politely say 'no'. QNTA simply has no $$ to pay any lawyer fees, even if they win in court. This is the problem with suing penny stocks. The insiders know upfront that they won't be sued for these very reasons.
Even if the SH coughed up the $$ to pay the lawyers....there are no $$ to win in the courts (QNTA is broke). Jail time would only occur if the lawyers can PROVE fraud, and that will not be easy to do. Remember - Innocent until proven guilty!
I agree completely! It’s time to take action.
I am sure there would be several investors who would be willing to cover this expense if QNTA is a legitimate organization. Arthur and Grant need to be replaced!
And where will you find the $$$ to pay that new CEO? From the company profits?
Arthur can and should be replaced! He should realize he has failed and over his head. They need to bring in a capable leader and let them run the business. Arthur can still stay in the back ground and be of extreme value, but someone else needs to run the company. It’s clear the SEC wants nothing to do with him.
In the field of law they call it "Deep Pockets". QNTA has no $$$ to pay those lawyers to fight for us.... assuming you/we win the court battle. You will not find a lawyer to work for you unless you pay them 'up front'. Lawyers want to be paid for their services rendered. Period.
Shoondale...so what is your plan? How are you going to influence/shape the outcome? What's your secret? What's your plan?
I’m not expecting anyone to do anything more than do their own DD. I simply was sharing the PR
Personally, I do believe they are working toward getting things in order … I also feel it’s been a heck of year … definitely a Murphy law kind of year …
I’m hopeful their perseverance will prevail as it’s about 20 years of research that unfortunately culminated at the height of the pandemic… which was unfortunate - so many things because of Covid caused delays and cancellations etc etc
I’m heavily invested, I like and use the products… my friends and parents who’ve I’ve gifted the muscle rub also like the product.
Everyone has to do what is best for themselves…. What’s best for me is to hold as selling isn’t an option.
I’ve had conversations with the Mikaelians and I’ve found them to be sincere, forthcoming and honest.
Again, everyone has to do what’s best for themselves. I’m simply sharing information.
GLTA
https://www.weny.com/story/47865534/quanta-and-medolife-rx-provide-updates-on-activities-and-plans
From the PR:
“
There is a revamp of the AELIA and Quanta products Amazon.com listings to improve the shopping experience. In addition, the Company has made the decision to have one exclusive seller on Amazon starting in December for the aforementioned products. By reducing the number of resellers for the products, the Company seeks to achieve stability in the product pricings on the platform.”
- As noted in the PR the products can be found on Amazon - here is the link verifying indeed as noted in pr they are attainable on Amazon :
https://www.amazon.com/AELIA-Organic-Hemp-Muscle-Rub/dp/B09H3QX8GD/ref=mp_s_a_1_1_sspa?crid=31GCAU59999K1&keywords=aelia+muscle+rub&qid=1672974931&sprefix=aeli%2Caps%2C109&sr=8-1-spons&psc=1&spLa=ZW5jcnlwdGVkUXVhbGlmaWVyPUEyMllYVDlTMllDVEhXJmVuY3J5cHRlZElkPUEwOTYyNjYzMTg5Rk45Qlk0VUc1UiZlbmNyeXB0ZWRBZElkPUEwOTM0MzQwM0RUVDVSMU1PQkNJTCZ3aWRnZXROYW1lPXNwX3Bob25lX3NlYXJjaF9hdGYmYWN0aW9uPWNsaWNrUmVkaXJlY3QmZG9Ob3RMb2dDbGljaz10cnVl
I suggest shareholders band together legally to remove this POS. Let's start doing to these SOB's what they did to us.
The Rosen Law Firm, P.A. is dedicated to recovering damages for shareholders victimized by corporate fraud and other misconduct. Our attorneys have a wealth of knowledge and experience handling complex financial litigation and winning significant victories and settlements for our clients. By focusing exclusively on securities class actions and derivative litigation, we have risen to the forefront of plaintiffs’ firms and have recovered damages totaling hundreds of millions of dollars for our clients. Our mission is to protect shareholders rights.
Followers
|
115
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
13742
|
Created
|
03/12/18
|
Type
|
Free
|
Moderators |
Quanta for 2021 will be undergoing a name change to be announced shortly as well as Quanta is in the process of expanding its product line from 4 SKUs to 38 by summer. We will also be introducing all new branding with new color schemes, new packaging, and exciting celebrity endorsements for the pain relief products and a newly introduced beauty product line. Quanta will also be working on a men’s cosmetic line in conjunction with one of the celebrity endorsements planned for late 2021. The company has hired an advertising agency to help with the rollout of the new branding expected second quarter 2021. This will work in conjunction with a major push the company is on the path of with some major big box retail chains.
Quanta Basics
Quanta is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables. Ultimately, Quanta’s mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.
The established resonance theory behind Quanta’s polarization process has many potential applications. From potentiating bio-ingredients to produce more-effective carbon-trapping plants to transformative anti-aging solutions Quanta’s technology has the opportunity to upend how commercial products are made and the benefits from them. Already we see multi-trillion-dollar global industries benefiting from Quanta’s technology.
Our proof of concept, Quanta’s market-leading CBD pain-relief rub (“Muscle Rub”), is only the first in a series of paradigm shift products to emerge from our labs. At the heart of its well-documented effectiveness is our proprietary “polarization” process, which uses electromagnetic force to markedly enhance bioactivity at the molecular level—a polarized active ingredient is more soluble and creates stronger bonds with the body’s receptors. This allows us to enhance ingredients so they work faster and more powerfully without the use of chemical by-products or cellular penetration. Quanta believes this natural solution has nearly limitless applications in the world of plant-based consumer products.
Quanta is involved in ambitious projects that we believe will reshape the next wave of climate science, sustainability, nutrition, and more. Having harnessed the technology of the future, Quanta is dedicated to bringing tomorrow’s health and wellness solutions to the billions in need today.
Discovery Synopsys
Using our product development process and business-to-business and direct-to-consumer sales approaches as a benchmark for future business, we developed the Quanta business model. Our technology’s unique ability to strengthen ingredients renders them more potent without added chemicals or penetrating cells means Quanta is in a first-of-its-kind position in the market. As the world’s first company focused on Quantum Biology we sit in a strong, but unique position in the market.
Our ability to increase ingredient efficacy by up to 500% means we are in a rare position to truly disrupt many areas of material science.
Quanta’s technology renders products superior to any on the market today. A 30% re-purchase rate (on one SKU alone) illustrates consumer appetite for the product.
Upcoming products and ventures will be designed to achieve or surpass this level of consumer benefit and uptake.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1691430/000149315221008846/form10-k.htm
Management Team
Arthur Mikaelian, Ph.D.
Chairman & CEO
One of Dr. Arthur Mikaelian’s greatest scientific contributions and groundbreaking inventions is Quantum Physics and Quantum Biology-based polarization technology, which targets molecular structure of the main ingredients in synthetic medications or natural compounds, leading to the increased potency of liquid and solid compounds, which substantially increases their therapeutic effectiveness. Dr. Mikaelian’s polarization technology has been awarded U.S. Patent 8,097,284B2 as it pertains to the Polarized Scorpion Venom solution. For the past 20 years, Dr. Mikaelian has been independently actively studying stress hormones (cortisol, epinephrine), and the master gene’s (ATF3) indirect influence on cancer cell activity and tumor progression. His initial findings quickly led him to the innovative creation of a new generation of pharmaceutical and nutraceuticals drugs, as well as expanding his interests in cancer and oncology.
Dr. Mikaelian’s education began in 1984 at the 2nd Medical Institute of Moscow and continued at the Vernadsky University of Biosphere Knowledge in Moscow, where he earned his doctorate in Biological/NeuroPsychology; he then went on to complete his postdoctoral work at Vernadsky. Dr. Mikaelian has broad experience with Quantum Physic and Quantum Biology. He also earned an MBA from the University of Bologna in Italy.
Khalid Matalka, Ph.D., SI(ASCP)
Chief Scientific Officer
Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992. After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI-ASCP) and a member at the American Society for Cancer Research since 1994.
Dr. Matalka enrolled in academia as an assistant professor in 1995, then promoted to associate and then a professor in 2004. Prof. Matalka held a dean position at two different academic institutions. Besides, Prof. Matalka was a consultant for twenty years to a JPM pharmaceutical company and a hospital diagnostic laboratory. During those 22 years, Prof. Matalka was heavily involved in research mainly on immunomodulation, cancer research, and development of immunological assays. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, MA as a Chief Biologist. While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma. In March 2020, Prof. Matalka joined Medolife Corporation as Chief Scientific Officer (CSO) and, in February 2021, became the CSO of the newly established Medolife Rx.
Prof. Matalka has 65 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals. Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
Grant Mikaelian
Executive Vice President
In 2013, Mr. Grant Mikaelian began working for an advanced biopharmaceutical company called Medolife. During his employment, he amassed a wide range of skills through managing various departments of the company. As a Marketing Sales Department Manager, he led many successful projects to improve customer experience through website development and design, enhanced customer support, streamlined ordering systems, configuration of B2C/B2B logistics, company rebranding, and preparation of marketing literature and presentations. He was later promoted to Operations Manager, overseeing and optimizing company departments on a larger scale. He was involved in production planning, project management of short and long-term goals, hiring prospective employees and contractors, corporate IT improvements, equipment procurement, international product registrations, due diligence preparation, and financial audits. He came to inspire confidence and began working closely with Dr. Arthur Mikaelian, CEO of Medolife. Soon after, Mr. Mikaelian was further promoted to Chief Business Development Officer. As the CBDO, he worked with existing and potential shareholders, was involved in domestic and international investment opportunities, managed multiple departments, increased company and product awareness, expanded product distribution channels, drafted Press Releases and articles, edited and proofread company literature, and more. Mr. Mikaelian is an organized leader with broad experiences in management and promotion of corporate growth.
Clemente Pascarella
Audit Committee
Christopher Rullan
Attorney for Mexico Division
Eduard Sahakyan
Head of R&D
Dr. Sahakyan started his career at Glendale Community College (GGC) as a lab technician for the biology department. He then pursued a biotechnology major at Pasadena City College (PCC). During his studies he interned at the Pasadena Bio Collaborative (PBC) Incubator as part of the LA Bioscience Hub research outreach program. Dr. Sahakyan worked with multiple companies including UCLA, Amgen and others during his summer internship. Upon completion, he was offered a permanent position at BCN (UCLA research collaborative) where he completed multiple projects, some of them are pending publication. In 2019, Dr. Sahakyan was offered a position in Medolife as a research associate. Within a year he was promoted to head scientist. Throughout this time, Dr. Sahakyan has worked on a number of company projects, which he presented at different local and national conferences. One of his bigger projects is the differentiation of embryonic stem cells into red blood cells. He continuously brings new ideas and initiatives to the company.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |